NO20003075L - Neurobeskyttende midler - Google Patents

Neurobeskyttende midler

Info

Publication number
NO20003075L
NO20003075L NO20003075A NO20003075A NO20003075L NO 20003075 L NO20003075 L NO 20003075L NO 20003075 A NO20003075 A NO 20003075A NO 20003075 A NO20003075 A NO 20003075A NO 20003075 L NO20003075 L NO 20003075L
Authority
NO
Norway
Prior art keywords
sup
group
aryl
alkyl
formula
Prior art date
Application number
NO20003075A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003075D0 (no
Inventor
Mark Bradley
Fausto Iannotti
Ashley Ker Pringle
Lars Eric Sundstrom
Original Assignee
Univ Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southampton filed Critical Univ Southampton
Publication of NO20003075D0 publication Critical patent/NO20003075D0/no
Publication of NO20003075L publication Critical patent/NO20003075L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Electrotherapy Devices (AREA)
NO20003075A 1997-12-16 2000-06-15 Neurobeskyttende midler NO20003075L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726569.8A GB9726569D0 (en) 1997-12-16 1997-12-16 Neuroprotective agents
PCT/GB1998/003775 WO1999031049A1 (en) 1997-12-16 1998-12-16 Neuroprotective agents

Publications (2)

Publication Number Publication Date
NO20003075D0 NO20003075D0 (no) 2000-06-15
NO20003075L true NO20003075L (no) 2000-08-15

Family

ID=10823695

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003075A NO20003075L (no) 1997-12-16 2000-06-15 Neurobeskyttende midler

Country Status (19)

Country Link
US (2) US6797699B1 (de)
EP (1) EP1040096B1 (de)
JP (1) JP2002508349A (de)
KR (1) KR20010033249A (de)
CN (1) CN1284058A (de)
AT (1) ATE244698T1 (de)
AU (1) AU739296B2 (de)
CA (1) CA2315258C (de)
DE (1) DE69816337T2 (de)
DK (1) DK1040096T3 (de)
ES (1) ES2201563T3 (de)
GB (1) GB9726569D0 (de)
HU (1) HUP0004486A3 (de)
IL (1) IL136800A (de)
NO (1) NO20003075L (de)
NZ (1) NZ505110A (de)
PT (1) PT1040096E (de)
RU (1) RU2205177C2 (de)
WO (1) WO1999031049A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7312244B2 (en) 1999-04-30 2007-12-25 Cellgate, Inc. Polyamine analog-amino acid conjugates useful as anticancer agents
GB2363983A (en) 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
CN1939529A (zh) 2002-01-29 2007-04-04 Wyeth公司 用于调节连接蛋白半通道的组合物和方法
GB0202645D0 (en) * 2002-02-05 2002-03-20 Univ Southampton Treatment of chronic neurodegenerative diseases
WO2008105441A1 (ja) * 2007-02-27 2008-09-04 Ajinomoto Co., Inc. リン吸収抑制活性を有するポリアミノ酸化合物及びリン吸収抑制剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2465303A (en) * 1939-04-03 1949-03-22 Research Corp Lactones
ES2039213T3 (es) * 1986-04-04 1993-09-16 Microbial Chemistry Research Foundation Procedimiento para producir nuevos compuestos relacionados con espergualina.
US6262125B1 (en) * 1986-12-02 2001-07-17 University Of Florida Research Foundation, Inc. Sterically hindered tetraamines and method for their production
US5242947A (en) 1988-02-10 1993-09-07 New York University Use of polyamines as ionic-channel regulating agents
WO1990014087A1 (en) * 1989-05-17 1990-11-29 Pfizer Inc. 2-piperidino-1-alkanol derivatives as antiischemic agents
IL94963A0 (en) 1989-07-03 1991-06-10 Univ New York Use of polyamines as ionic-channel regulating agents
RU2119496C1 (ru) * 1992-04-14 1998-09-27 Научно-исследовательский институт фармакологии Российской академии медицинских наук Производные n-ацилпролилдипептидов
SE9302334D0 (sv) * 1993-07-06 1993-07-06 Ab Astra New compounds
SE9302332D0 (sv) * 1993-07-06 1993-07-06 Ab Astra New compounds
SE9302333D0 (sv) * 1993-07-06 1993-07-06 Ab Astra New compounds
FR2773798B1 (fr) * 1998-01-16 2001-02-02 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
IL136800A0 (en) 2001-06-14
DK1040096T3 (da) 2003-10-20
US6797699B1 (en) 2004-09-28
ES2201563T3 (es) 2004-03-16
US7026297B2 (en) 2006-04-11
IL136800A (en) 2005-07-25
AU1571799A (en) 1999-07-05
RU2205177C2 (ru) 2003-05-27
KR20010033249A (ko) 2001-04-25
WO1999031049A1 (en) 1999-06-24
GB9726569D0 (en) 1998-02-11
HUP0004486A2 (hu) 2001-05-28
EP1040096A1 (de) 2000-10-04
HK1029331A1 (en) 2001-03-30
DE69816337T2 (de) 2004-04-15
JP2002508349A (ja) 2002-03-19
CN1284058A (zh) 2001-02-14
DE69816337D1 (de) 2003-08-14
CA2315258A1 (en) 1999-06-24
NO20003075D0 (no) 2000-06-15
US20040106560A1 (en) 2004-06-03
AU739296B2 (en) 2001-10-11
EP1040096B1 (de) 2003-07-09
ATE244698T1 (de) 2003-07-15
PT1040096E (pt) 2003-09-30
NZ505110A (en) 2003-01-31
CA2315258C (en) 2008-07-15
HUP0004486A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
CA2171275A1 (en) Stilbene derivatives and pharmaceutical compositions containing them
BR9106819A (pt) Polimeros contendo unidades diester,processo para a preparacao de um polimero e compostos
CA2078790A1 (en) 3-benzylidene-1-carbamoyl-2-pyrrolidone analogues
GB0019359D0 (en) Novel guanidines
ES2187473T3 (es) Triarylimidazoles.
AP2003002841A0 (en) Quinazolines as MMP-13 inhibitors
CA2325741A1 (en) Urea derivatives having tnf- .alpha. production inhibitory effects
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
CA2057786A1 (en) Amino and nitro containing tricyclic compounds useful as inhibitors or ace
EP1184373A4 (de) Tricyclische verbindungen
NO20003773L (no) Syklobutenderivater, deres fremstilling og deres terapeutiske anvendelser
CA2045857A1 (en) Diaminotrifluoromethylpyridine Derivatives, Process for Their Production and Phospholipase A2 Inhibitor Containing Them
DK1040096T3 (da) Neurobeskyttende midler
ES2044781A1 (es) Procedimiento para la preparacion de nuevas amidas con accion inhibidora de la fosfolipasa a2
EP0567090A3 (de)
FR2672213B1 (fr) Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres.
WO2000063222A3 (fr) Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
DE68927554D1 (de) Cephalosporinverbindungen und Verfahren zu ihrer Herstellung
DE69007356D1 (de) Zyklisches Tetrapeptid und Verfahren zu dessen Herstellung.
ATE36705T1 (de) Arzneimittel auf basis von piperidinderivaten, piperidinderivate und verfahren zu ihrer herstellung.
NO980994L (no) Substituerte fosfinsyreforbindelser og deres anvendelse som farmas÷ytika
RU2000116112A (ru) Нейрозащитные агенты
DK0619817T3 (da) Hidtil ukendte farmaceutisk aktive flaviliumforbindelser
DE60007984D1 (de) Antioxidantien, verfahren zu ihrer herstellung und ihre verwendungen
CA2109800A1 (en) N-Hydroxyurea Derivatives Which Inhibit Lipoxygenase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application